Piscitello Charlie 4

4 · Acutus Medical, Inc. · Filed Aug 1, 2022

Form 4

Period: 2022-07-25

Chief People Officer

Transactions

Award
Employee Stock Options (Right to Buy)
2022-07-25+34,800→ 146,740 total
Exercise: $1.34Exp: 2031-04-01→ Common Stock (34,800 underlying)
Disposition to Issuer
Employee Stock Options (Right to Buy)
2022-07-25−51,418→ 95,322 total
Exercise: $13.38Exp: 2029-09-10→ Common Stock (51,418 underlying)
Award
Employee Stock Options (Right to Buy)
2022-07-25+51,418→ 146,740 total
Exercise: $1.34Exp: 2029-09-10→ Common Stock (51,418 underlying)
Award
Employee Stock Options (Right to Buy)
2022-07-25+28,022→ 146,740 total
Exercise: $1.34Exp: 2030-08-05→ Common Stock (28,022 underlying)
Disposition to Issuer
Employee Stock Options (Right to Buy)
2022-07-25−28,022→ 118,718 total
Exercise: $18.00Exp: 2030-08-05→ Common Stock (28,022 underlying)
Disposition to Issuer
Employee Stock Options (Right to Buy)
2022-07-25−34,800→ 111,940 total
Exercise: $13.66Exp: 2031-04-01→ Common Stock (34,800 underlying)
Disposition to Issuer
Employee Stock Options (Right to Buy)
2022-07-25−32,500→ 114,240 total
Exercise: $2.41Exp: 2032-02-01→ Common Stock (32,500 underlying)
Award
Employee Stock Options (Right to Buy)
2022-07-25+32,500→ 146,740 total
Exercise: $1.34Exp: 2032-02-01→ Common Stock (32,500 underlying)

Holdings

Footnotes (4)

[F1]The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on September 10, 2019, with 1/4 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 36 equal monthly installments.
[F2]The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on August 5, 2020, with 1/4 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 36 equal monthly installments.
[F3]The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on April 1, 2021, with 1/4 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 36 equal monthly installments.
[F4]The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on February 1, 2022, with 1/2 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 12 equal monthly installments.

Documents

1 file